These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23222413)

  • 1. Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal cancer.
    Jiang Y; Turgeon DK; Wright BD; Sidahmed E; Ruffin MT; Brenner DE; Sen A; Zick SM
    Eur J Cancer Prev; 2013 Sep; 22(5):455-60. PubMed ID: 23222413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer.
    Zick SM; Turgeon DK; Ren J; Ruffin MT; Wright BD; Sen A; Djuric Z; Brenner DE
    Mol Carcinog; 2015 Sep; 54(9):908-15. PubMed ID: 24760534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer.
    Zick SM; Turgeon DK; Vareed SK; Ruffin MT; Litzinger AJ; Wright BD; Alrawi S; Normolle DP; Djuric Z; Brenner DE
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1929-37. PubMed ID: 21990307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.
    Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L
    Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).
    Fink SP; Yamauchi M; Nishihara R; Jung S; Kuchiba A; Wu K; Cho E; Giovannucci E; Fuchs CS; Ogino S; Markowitz SD; Chan AT
    Sci Transl Med; 2014 Apr; 6(233):233re2. PubMed ID: 24760190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-21-mediated regulation of 15-hydroxyprostaglandin dehydrogenase in colon cancer.
    Monteleone NJ; Moore AE; Iacona JR; Lutz CS; Dixon DA
    Sci Rep; 2019 Apr; 9(1):5405. PubMed ID: 30931980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase.
    Dai L; Perera DS; King DW; Southwell BR; Burcher E; Liu L
    J Pharmacol Exp Ther; 2012 Jan; 340(1):27-36. PubMed ID: 21957267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variability in key genes in prostaglandin E2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development.
    Pereira C; Queirós S; Galaghar A; Sousa H; Pimentel-Nunes P; Brandão C; Moreira-Dias L; Medeiros R; Dinis-Ribeiro M
    PLoS One; 2014; 9(4):e92000. PubMed ID: 24694755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha.
    Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
    Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
    Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells.
    Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A
    Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers.
    Yan M; Rerko RM; Platzer P; Dawson D; Willis J; Tong M; Lawrence E; Lutterbaugh J; Lu S; Willson JK; Luo G; Hensold J; Tai HH; Wilson K; Markowitz SD
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17468-73. PubMed ID: 15574495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
    Backlund MG; Mann JR; Holla VR; Buchanan FG; Tai HH; Musiek ES; Milne GL; Katkuri S; DuBois RN
    J Biol Chem; 2005 Feb; 280(5):3217-23. PubMed ID: 15542609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E
    Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
    Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-catenin represses expression of the tumour suppressor 15-prostaglandin dehydrogenase in the normal intestinal epithelium and colorectal tumour cells.
    Smartt HJ; Greenhough A; Ordóñez-Morán P; Talero E; Cherry CA; Wallam CA; Parry L; Al Kharusi M; Roberts HR; Mariadason JM; Clarke AR; Huelsken J; Williams AC; Paraskeva C
    Gut; 2012 Sep; 61(9):1306-14. PubMed ID: 22082586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.
    Myung SJ; Rerko RM; Yan M; Platzer P; Guda K; Dotson A; Lawrence E; Dannenberg AJ; Lovgren AK; Luo G; Pretlow TP; Newman RA; Willis J; Dawson D; Markowitz SD
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12098-102. PubMed ID: 16880406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burn injury with infection alters prostaglandin E2 synthesis and metabolism.
    Hahn EL; Tai HH; He LK; Gamelli RL
    J Trauma; 1999 Dec; 47(6):1052-7; discussion 1057-9. PubMed ID: 10608532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression.
    Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA
    Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-hydroxyprostaglandin dehydrogenase in colorectal mucosa as a potential biomarker for predicting colorectal neoplasms.
    Lee HJ; Yang DH; Ryu YM; Song M; Song HJ; Jung KW; Kim KJ; Ye BD; Byeon JS; Choi EK; Yang SK; Kim JH; Myung SJ
    J Korean Med Sci; 2013 Aug; 28(8):1154-60. PubMed ID: 23960441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of cytosolic phospholipase A2, 15-prostaglandin dehydrogenase, and cyclooxygenase-2 expressions on tumor progression in colorectal cancer.
    Lim SC; Cho H; Lee TB; Choi CH; Min YD; Kim SS; Kim KJ
    Yonsei Med J; 2010 Sep; 51(5):692-9. PubMed ID: 20635443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.